Antifol 100

We are engaged in exporting, manufacturing and supplying of Antifol 100 in Mumbai, Maharashtra, India.

A. Nonsquamous Non-Small Cell Lung Cancer-Combination with Cisplatin

Pemetrexed is indicated in combination with cisplatin therapy for the initial treatment of patients with Locally advanced or metastatic nonsquamous non-small cell lung cancer.

B. Nonsquamous Non-Small Cell Lung Cancer-Maintenance

Pemetrexed is indicated for the maintenance treatment of patients with locally advanced or metastaticnonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.

C. Nonsquamous Non-Small Cell Lung Cancer After Prior Chemotherapy

Pemetrexed is indicated as a single-agent for the treatement of patients with locally advanced or metastaticnonsquamous non-small cell lung cancer after prior chemotherapy.

D. Mesothelioma

Pemetrexed in combination with cisplatin in indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.

Limitations of Use Pemetrexate is not indicated for the treatment of patients with squamous cell non-small cell lung cancer.
Antifol